Ares D Tablet
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
MFDS item code 201904555 · Approved 2019.07.04
This product's status changed to Approval withdrawn on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome
This medication is used to treat ulcers of the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and reflux esophagitis. It is also effective in preventing Mendelson's syndrome before anesthesia and treating postoperative ulcers. It helps with gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to address various gastrointestinal ailments.
○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by administration of nonsteroidal anti-inflammatory drugs or for concomitant use to prevent gastric or duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by administration of nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, the maintenance dose is 1 tablet once daily at bedtime. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. However, the dose may be increased to 2 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis or with poor kidney function. Patients who have had allergic reactions to this medicine or its components should not use it. Patients with a history of acute porphyria may experience seizures, so this medication should not be given. Patients who have had gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, and newborns should not take this medication. Patients on a potassium-restrictive diet should be cautious. Patients with liver dysfunction, a history of drug allergies, elderly patients, and those with a history of kidney impairment should use this medication carefully. Elderly patients or those with a history of gastric ulcers who take NSAIDs need regular monitoring. This medication may mask symptoms of gastric cancer, so it should be administered only after confirming malignancy in cases of newly presented dyspepsia in gastric ulcer patients or those over middle age. Patients with gastric and duodenal ulcers associated with Helicobacter pylori need eradication therapy. Severely ill patients in intensive care units, patients with hypophosphatemia, and patients who have difficulty swallowing need caution with this medication. This medication may rarely cause allergic reactions, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, neurological symptoms, skin rashes, and other various side effects; if any adverse symptoms occur, discontinue use immediately and consult a doctor. Long-term continuous use should be avoided, and the treatment progress should be closely monitored, using only the necessary minimum dosage. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems may have an increased risk of pneumonia and need to be careful. If dizziness or drowsiness occurs while taking this medication, avoid driving or operating dangerous machinery. This medication can interact with other drugs; therefore, especially when taken with anticoagulants, certain antibiotics, or anticonvulsants, inform your doctor or pharmacist, and the dosing intervals may need adjustment. It is safest for pregnant or breastfeeding women to avoid this medication, and safety in children has not been established, so use is not recommended. This medication can affect some clinical test results, so it is important to inform the healthcare team during testing. In cases of overdose, emergency treatments like vomiting or gastric lavage may be needed, so visit a medical facility immediately. This medication may reduce gastric acid secretion, promoting bacterial growth in the gastrointestinal tract, and prolonged use may require ophthalmic examinations.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, avoid extremely hot or cold places, and it is recommended to store it at room temperature between 1 to 30 degrees.
Greenish rectangular film-coated tablet
300 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.